Spyre Therapeutics, Inc. (SYRE)

44.21 +1.00 (+2.31%) USD  |  NASDAQ  |  Feb 23, 16:00
44.21 0.00 (0.00%) After-Hours: 18:01
More

Spyre Therapeutics Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
PTC Therapeutics, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade